Does Dr. WALID ABBOUD have financial conflicts of interest?

Dr. WALID ABBOUD (MD) has received a total of $3,984 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $3,984 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. WALID ABBOUD?

According to CMS Open Payments data, Dr. WALID ABBOUD received funding from BOEHRINGER INGELHEIM PHARMACEUTICALS ($1,849), ESPERION THERAPEUTICS ($1,112), and ASTRAZENECA PHARMACEUTICALS ($478).

Does Dr. WALID ABBOUD receive research grants or speaking fees?

Dr. WALID ABBOUD has received $3,984 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. WALID ABBOUD

MDReal-Time Hydrated

Specialty: Internal Medicine

Practice Location: CLEVELAND, OH 44195

NPI Number: 1245295559

LIFETIME INDUSTRY VALUE

$3,984

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. ABBOUD is a verified Internal Medicine practitioner based in CLEVELAND, OH.

Between 2021 and 2025, Dr. ABBOUD had an overall industry promotional and research financial footprint of $3,984 as recorded in the federal CMS Open Payments database.

$3,984 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ABBOUD's primary funding source is BOEHRINGER INGELHEIM PHARMACEUTICALS, which accounts for $1,849 (representing 46.4% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

BOEHRINGER INGELHEIM PHARMACEUTICALS

Rank 1

$1,849

46.4%

ESPERION THERAPEUTICS

Rank 2

$1,112

27.9%

ASTRAZENECA PHARMACEUTICALS

Rank 3

$478

12%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.